These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 12716522

  • 41. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
    Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG.
    J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
    [Abstract] [Full Text] [Related]

  • 42. [Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis].
    Guo JX, Ma HB, Li YL, Xu J, Yang LH, Shi JB, Li B, Liu AX, Li XX, Li BA, Mao YL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):71-3. PubMed ID: 19799025
    [Abstract] [Full Text] [Related]

  • 43. Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis.
    Lesmana CR, Hasan I, Budihusodo U, Gani RA, Krisnuhoni E, Akbar N, Lesmana LA.
    J Dig Dis; 2009 Aug; 10(3):201-6. PubMed ID: 19659788
    [Abstract] [Full Text] [Related]

  • 44. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
    Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR.
    J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526
    [Abstract] [Full Text] [Related]

  • 45. [Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B].
    Dong Z, Shen H, Zhang FK.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):129-31. PubMed ID: 17653313
    [Abstract] [Full Text] [Related]

  • 46. [Correlation between HBsAg, HCV expression in cancerous and pericancer tissues of hepatocellular carcinoma and liver fibrosis markers in serum].
    Xin YN, Xuan SY, Shi GJ, Chen H, Sun Y, Zhang J.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):513-5. PubMed ID: 16042887
    [Abstract] [Full Text] [Related]

  • 47. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL, Brown RM, Tybulewicz A, Hayes P, Wilson DC, Gillett P, McKiernan P.
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [Abstract] [Full Text] [Related]

  • 48. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
    Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S, Diamantis I.
    Liver Int; 2006 Sep; 26(7):864-71. PubMed ID: 16911470
    [Abstract] [Full Text] [Related]

  • 49. [Diagnostic values of serum levels of HA, PC III, C IV and LN to the liver fibrosis in children with beta-thalassemia major].
    Xu HG, Fang JP, Huang SL, Li HG, Zhong FY, Guo HX, Su H.
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):603-6. PubMed ID: 14744384
    [Abstract] [Full Text] [Related]

  • 50. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
    Cheong JY, Um SH, Seo YS, Shin SS, Park RW, Kim DJ, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB, Park YN, Cho SW.
    Hepatogastroenterology; 2012 Aug; 59(120):2592-7. PubMed ID: 23178625
    [Abstract] [Full Text] [Related]

  • 51. [Accurate diagnosis of stages of hepatic fibrosis by measuring levels of serum hyaluronic acid, procollagen type III, and collagen type IV].
    Xie S, Yao J, Zheng R, Peng X, Gao Z.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Dec; 9(6):334-6. PubMed ID: 11782298
    [Abstract] [Full Text] [Related]

  • 52. [The relationship of serum metalloproteinase with the severity of liver fibrosis and inflammation].
    Yin SS, Li XM, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):666-8. PubMed ID: 15623375
    [Abstract] [Full Text] [Related]

  • 53. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 54. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K.
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [Abstract] [Full Text] [Related]

  • 55. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML.
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [Abstract] [Full Text] [Related]

  • 56. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K.
    Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429
    [Abstract] [Full Text] [Related]

  • 57. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M.
    Acta Biochim Pol; 2011 Aug; 58(4):563-6. PubMed ID: 22140659
    [Abstract] [Full Text] [Related]

  • 58. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP.
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [Abstract] [Full Text] [Related]

  • 59. [Clinical study on treatment of cirrhosis by different dosages of salvia injection].
    Ye F, Liu Y, Qiu G, Zhao Y, Liu M.
    Zhong Yao Cai; 2005 Sep; 28(9):850-4. PubMed ID: 16447879
    [Abstract] [Full Text] [Related]

  • 60. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
    Boursier J, Bacq Y, Halfon P, Leroy V, de Ledinghen V, de Muret A, Bourlière M, Sturm N, Foucher J, Oberti F, Rousselet MC, Calès P.
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):28-38. PubMed ID: 19060630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.